Potential market

SECTION I: The product

 

1a The innovation potential of this product is related to:

 

  • Technology-driven innovation (under the influence of the development of science – the market is not ready for the product)
  • Market-driven innovation (as a result of market surveys, the market expects the product)
  • Replacement of existing product
  • Product related to cost reduction
  • Radical new product
  • Other, what…
  • Market-driven innovation (as a result of market surveys, the market expects the product)
  • Replacement of existing product
  • Product related to cost reduction

 

 

1b What added value for end-users does the product hold?
• higher quality
• Better technical characteristics
• Other …
• Higher quality, safe diagnosis

• Better technical characteristics by means of selectivity and sensitivity

• Cost-effective, point of care diagnosis

• Does not need direct manipulations with the pathogen

• Simple, does not require instruments, laboratory and skilled caretakers

1c What is the Unique Sales Proposition of the potential product?
Diagnostic tool with the above characteristics is missing; appearance of a TB diagnostics of this type is expected by the WHO not earlier than 2015.

 

 

 

 

SECTION 2: The Market

 

2a What is the target market for the product?

National ¨

European ¨

Global X¨

Please describe the characteristics of your target market.

The robust, simple and inexpensive diagnostic tool with high specificity and selectivity will be offered to healthcare providers in low-income countries where TB is endemic, as well as in rapidly developing countries including Russian Federation, Republic of India, and People’s Republic of China, where tuberculosis poses an obstacle for economic development.

Sub-Saharan Africa is a target market as well. Implementation of our diagnostic tool needs support of the WHO and governments of the industrialized world.

As European market beyond Russian Federation Romania should take into consideration, where the prevalence of TB is among the highest in the continent.

 

2b How the product is characterized from the following options? Number of companies producing similar products in the field.

• Base – applied by all companies in the industry

• Leading – applied by a single or limited number of competitive companies

• Key –at a development stage, but has already proven its potential

At the moment this product does not exist. To create a robust, simple and inexpensive diagnostic tool for TB is highly desired by WHO. These research efforts are basically funded by governments of the industrialized world and by private foundations following recognition TB as global burden of the mankind. Basically, development takes place in developed countries, whereas the tools in combating against TB will be applied in less developed or resource-poor countries.

Producing of the product is at base level, applied by all companies in the pharmaceutical industry.

 

 

 

2c What type of market demand will be satisfied?

• Existing demand – the market is already developed

• hidden (latent) demand – the market has yet to be developed

Existing demand – the market is already developed; implementations of new technologies against TB, including new diagnostic tools are highly desired.

2d What is the current stage of the product’s market life cycle?

• Implementation, implementation in production (leading to a radically new product offers)

• Growth (rapid spread within the industry or outside it)

• maturity (parameters of the technical characteristics of manufactured products reached their maximum, higher-grade products can be manufactured on the basis of technological substitution)

• Implementation, implementation in production (leading to a radically new product offers)

 

 

 

 

 

2e Strategic partnerships (existing or potential).
Allan Riting Liu, M.D., Ph.D., M.B.A.

Vice President, Wanbang Biopharmaceutical Co. Ltd

Chief Director of Business Development, Fosun Pharmaceutical Group

Jennie, Wenjing Zhong, BD Manager

268 South Zhongshan Road, Building 1, Floor 17, Shanghai 200010, P.R.China

86-21-63325521 (Office); 86-13472551087 (Mobile)

86-21-63325580 (Fax)

 

Professor Dragulescu I. Stefan M.D., Ph.D. – Rector

Phone:+40-56-293389

Fax:+40-56-190626

CLINICAL DEPARTMENTS of Hygienics, Infectious Diseases

FACULTY OF GENERAL MEDICINE

The University of Medicine and Pharmacy of Timisoara

Romania

SECTION 3: The Competition

3a What is the competition within your target market?
At the moment no company offers simple diagnostic tool for TB.

 

 

 

 

3b What competitive advantages will the introduction of the new product ensue?

• lower prices based on lower production costs

• product differentiation (uniqueness of the product proposal)

Simplicity, robustness, less laborious, requires medium-trained health providers, high throughput enables ~60 diagnoses daily by one health provider, lower prices (USD 10/diagnosis)

 

 

 

 

 

 

3c Potential products relate to the following price range:

• High price range

• Average price range

• Low price range

• Low price range

 

 

 

 

 

3d Potential products will be marketed:

• To regulated markets (e.g. heat supply, water supply, universal telecommunication services, agricultural products, fishing industry, architectural services)

• To markets operating on the principle of free negotiation between agents on the market

To markets operating on the principle of free negotiation between agents on the market, as usually happens in the field of health industry.

Prices will depend on community support (government, civil organizations) in low resource countries.

 

 

SECTION 4: Indicators

 

Estimated cost of the new products € 80
Expected market volume (potential / maximum number of users) Hundreds of millions
Expected sales volume Tens of millions
Expected market share of the company (proportion between sales and total company sales in the relevant market) 0.1-5 %

 

KEYWORDS QUANTITATIVE ASSESSMENT (0-5).

 

Please put X as appropriate. 1 2 3 4 5
Added-value potential         X
Size of future market demand         X
Competitive positioning of the product         X

 

Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback: Trackback URL.

Post a Comment

You must be logged in to post a comment.

Request a proposal

Valorisation Plan Authors

Related Documents

There in no related documents

Visit the other applications of the INTERVALUE Platform: R&D Repository | IP Agreements

© 2009-2010 INTERVALUE Project